Disparities Among Liver Transplant Patients

Mayo Clinic

Status: Enrolling

Conditions: End Stage Liver DIsease

Study type: Observational

Funder types: Other

Identifiers

NCT05981196

22-008581

Details and patient eligibility

About

The purpose of this study is to inform healthcare interventions to reduce the disparities in liver transplant listing and in transplantation.

Full description

Aim 1. Establish a longitudinal cohort of patients with end-stage liver dysfunction.

Aim 2. Examine interpersonal and structural factors associated with liver transplant evaluation and listing by patient characteristics (e.g., race, ethnicity, SES, gender).

Aim 3. Examine the use of stigmatizing language among patients undergoing liver transplant based on their demographic characteristics (e.g., race, ethnicity, SES, gender).

Enrollment: 100 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with end-stage liver, kidney, or cardiac dysfunction.

Exclusion criteria

• Patients with more than one system with end stage organ dysfunction, dementia, cognitive or sensory impairment, prior solid organ transplant.
• Patients with potential medical exclusions for transplant.

Trial design

100 participants in 1 patient group

Liver Transplant Patients

Description:

Subjects with end-stage liver disease and being referred for transplant evaluation will fill out questionnaires about their background, emotions, and behaviors.